Matuzumab Completed Phase 2 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00111839Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer